MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10549-017-4254-0
Published Online: 2017-04-21
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
van Ramshorst, Mette S.
Loo, Claudette E.
Groen, Emilie J.
Winter-Warnars, Gonneke H.
Wesseling, Jelle
van Duijnhoven, Frederieke
Peeters, Marie-Jeanne T. Vrancken
Sonke, Gabe S.
License valid from 2017-04-21